Multiple-conformation and protonation-state representation in 4D-QSAR: The neurokinin-1 receptor system

Journal of Medicinal Chemistry

Volumn 43, Issue 23, 2000, Pages 4416-4427

  Vedani, A ^a   Briem, H ^a,b   Dobler, M ^a,c   Dollinger, H ^a,b   McMasters, D R ^a,d  

^a Biographics Laboratory 3R   (Switzerland)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c ETH ZURICH   (Switzerland)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST;

ALGORITHM; ANALYTIC METHOD; ARTICLE; DRUG ACTIVITY; DRUG CONFORMATION; LIGAND BINDING; MOLECULAR EVOLUTION; PREDICTION; PROTON TRANSPORT; SIMULATION; STRUCTURE ACTIVITY RELATION;

COMBINATORIAL CHEMISTRY TECHNIQUES; LIGANDS; MODELS, MOLECULAR; PROTONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, NEUROKININ-1;

EID: 0034676316     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000986n     Document Type: Article

References (55)

1. Receptors and antagonists for substance P and related peptides
2. The tachykinin NK-1 receptor. Part I: Ligands and mechanisms of cellular activation
3. An unidentified depressor substance in certain tissue extracts
4. The dual nature of the tachykinin NK-1 receptor
5. Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the NK-1 receptor
6. N-Heteroaryl-2-phenyl-3-(benzyloxy)-piperidines: A novel class of potent orally active human NK-1 antagonists
7. Structure and function of receptors coupled to G proteins
8. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1-receptor with fluorescent ligands
9. The structure of bacteriorhodopsin
10. High-resolution X-ray strucuture of an early intermediate in the Bacteriorhodopsin photocycle
11. Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP-96,345
12. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor
13. Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists
14. Identification of critical functional groups within binding pockets of G-protein-coupled receptors
15. Synthesis and biological evaluation of novel NK-1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template
16. Pseudoreceptors
17. Pseudoreceptor modeling: The construction of three-dimensional receptor surrogates
18. PrGen: Pseudoreceptor modeling using receptor-mediated ligand alignment and pharmacophore equilibration
19. PNP inhibitors
20. QSAR and 3D QSAR in drug design. 1. Methodology
21. QSAR and 3D QSAR in drug design. 2. Applications and problems
22. QSAR: Current state scope, and limitations
23. Construction of 3D-QSAR models using 4D-QSAR analysis formalism
24. Three-dimensional quantitative structure-activity relationships from molecular similarity matrixes and genetic neural networks
25. Catalyst pharmacophore models and their utility as queries for searching 3D databases
26. Quasi-atomistic receptor surface models: A bridge between 3-D QSAR and receptor modeling
27. Multi-conformational ligand representation in 4D-QSAR: Reducing the bias associated with ligand alignment
28. Multidimensional QSAR in drug research: Predicting binding affinities, toxicity, and pharmacokinetic parameters
29. Receptor surface models. 1. Definition and construction
30. Three-dimensional receptor modeling using distance geometry and Voronoi polyhedra
31. Genetically evolved receptor models: A computational approach to construction of receptor models
32. Receptor surface models. 2. Application to quantitative structure-activity studies
33. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors
34. Self-organizing molecular field analysis: A tool for structure-activity studies
35. Genetic function approximation to generate a family of QSAR equations using genetic algorithms
36. Molecular mechanics simulation of protein-ligand interactions: Binding of thyroid analogues to prealbumin
37. Semianalytical treatment of solvation for molecular mechanics and dynamics
38. The cost of conformational order: Entropy changes in molecular associations
39. A new force field for modeling metalloproteins
40. Preparation of arylglycinamide derivatives as tachykinin antagonists
41. An internal coordinate Monte Carlo method for searching conformational space
42. MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics
43. An efficient Newton-like method for molecular mechanics energy minimization of large molecules
44. A new force field for molecular-mechanical simulation of nucleic acids and proteins
45. Atomic charges derived from semiempirical methods
46. MOPAC - A semiempirical molecular orbital program
47. Ground states of molecules. The MNDO method. Approximations and parameters
48. A receptor: Modeling racemic mixtures in 4D-QSAR